QI QI CHEN
Physician Assistant at Main St, Flushing, NY
License number
New York 021244
Category
Nursing
Type
Physician Assistant
Address
Address
2
5645 Main St, Flushing, NY 11355
8147 102Nd Rd, Jamaica, NY 11416
8147 102Nd Rd, Jamaica, NY 11416
Phone
(718) 670-2000
(718) 772-5881
(718) 772-5881
Personal information
See more information about QI QI CHEN at radaris.comName
Address
Phone
964 58Th St FL 1, Brooklyn, NY 11219
512 E 80Th St #15, New York, NY 10075
454 W 36Th St #3RW, New York, NY 10018
5133 Goldsmith St #6F, Elmhurst, NY 11373
1245 Park Ave #G, New York, NY 10128
Professional information
Hepatitis C Virus Inhibitors
US Patent:
2014001, Jan 16, 2014
Filed:
Sep 16, 2013
Appl. No.:
14/027531
Inventors:
John A. Bender - Middletown CT, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Carol Bachand - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Qi Chen - Elmhurst NY, US
Makonen Belema - North Haven CT, US
John F. Kadow - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
Jeffrey Lee Romine - Meriden CT, US
Edward H. Ruediger - Greenfield Park, CA
Carol Bachand - Candiac, CA
Omar D. Lopez - Wallingford CT, US
Qi Chen - Elmhurst NY, US
Makonen Belema - North Haven CT, US
John F. Kadow - Wallingford CT, US
Lawrence G. Hamann - North Grafton MA, US
International Classification:
C07D 417/14, C07D 405/14, C07D 401/14, C07D 403/14, C07D 409/14, C07D 413/14
US Classification:
514316, 5483131, 514397, 548204, 514365, 548236, 514374, 546187, 5483121
Abstract:
This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Hepatitis C Virus Inhibitors
US Patent:
2013011, May 9, 2013
Filed:
Nov 8, 2012
Appl. No.:
13/672266
Inventors:
Bristol-Myers Squibb Company - Princeton NJ, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Makonen Belema - North Haven CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Elmhurst NY, US
Gan Wang - Cheshire CT, US
Piyasena Hewawasam - Middletown CT, US
John A. Bender - Middletown CT, US
Zhong Yang - Southington CT, US
Makonen Belema - North Haven CT, US
Omar D. Lopez - Wallingford CT, US
Qi Chen - Elmhurst NY, US
Gan Wang - Cheshire CT, US
Piyasena Hewawasam - Middletown CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 403/14, A61K 31/4545, C07D 401/14, A61K 31/437, C07D 471/04, A61K 31/4985, C07D 487/04, C07D 405/14, A61K 31/498, A61K 31/4178, A61K 31/4375, A61K 31/4709, A61K 31/5377, C07D 413/14, C07D 403/10, A61K 45/06, A61K 31/4184
US Classification:
424 852, 424 857, 514394, 5483054, 514316, 546187, 514303, 546118, 514249, 544350, 5483131, 544353, 514397, 546122, 514300, 546167, 514314, 5142322, 544 82, 5483137, 514 43, 514 44 A
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.